Vasopressin as a catecholamine-sparing adjunct in septic shock
Second-line vasopressor · Shock / Sepsis
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Adding fixed-dose vasopressin to noradrenaline in septic shock to reduce catecholamine requirement and restore vascular tone via V1 receptors, exploiting the relative vasopressin deficiency of sepsis. Given at a fixed rate, not titrated.
Red flags
- Rising dose despite combination therapy (refractory shock)
- New digital cyanosis or mottling
- Abdominal pain / rising lactate suggesting mesenteric ischaemia
- Bradycardia or falling cardiac output
- Attempting to titrate vasopressin upward for hypotension
Assessment
Differential diagnosis
- Catecholamine-resistant septic shock
- Vasoplegia (post-cardiopulmonary bypass, liver failure)
- Mixed septic/cardiogenic shock
- Occult hypovolaemia
- Adrenal insufficiency contributing to shock
Investigations
- Serial lactate and ScvO2
- Arterial line for continuous MAP
- U&E, LFTs, bilirubin (digital/mesenteric ischaemia risk)
- Echocardiography to exclude low cardiac output
- Cumulative noradrenaline dose trend
Management
- Confirm adequate fluid resuscitation and that noradrenaline is already running (typically ≥0.25-0.5 mcg/kg/min)
- Add fixed-dose vasopressin as a catecholamine-sparing agent, not as a titratable pressor
- Do not up-titrate vasopressin beyond the recommended ceiling to chase MAP — adjust noradrenaline instead
- Reassess perfusion (lactate clearance, urine output, capillary refill) after 1-2 h
- Monitor for digital, mesenteric and cardiac ischaemia
- Wean noradrenaline first once stable, leaving vasopressin until last or per unit protocol
- Consider adding hydrocortisone if shock remains vasopressor-dependent
Drugs & doses
Vasopressin — 20 units in 50 mL 0.9% saline (0.4 units/mL), run at 0.03 units/min fixed (4.5 mL/h); do not exceed 0.04 units/min
Noradrenaline — 0.05-1 mcg/kg/min IV titrated to MAP ≥65 mmHg (background agent)
Hydrocortisone — 50 mg IV QDS (or 200 mg/24 h infusion) if vasopressor-dependent
Disposition
Manage in critical care with invasive monitoring; wean catecholamines before vasopressin unless local protocol dictates otherwise.
Complications & pitfalls
- Peripheral/digital ischaemia and skin necrosis
- Mesenteric ischaemia
- Reduced cardiac output / coronary vasoconstriction
- Hyponatraemia
- Rebound hypotension on abrupt discontinuation
Exam pearls
- Vasopressin is dosed, not titrated — fixed at 0.03 units/min
- Its catecholamine-sparing effect lowers noradrenaline-related arrhythmia and tachycardia burden
- Introduce it earlier rather than at maximal noradrenaline for best sparing effect
- Watch the fingers and gut — ischaemia is the characteristic toxicity
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.